168 related articles for article (PubMed ID: 2841854)
1. Management of Epstein-Barr virus infections.
Andersson J; Ernberg I
Am J Med; 1988 Aug; 85(2A):107-15. PubMed ID: 2841854
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects on Epstein-Barr virus infection.
Andersson JP
Scand J Infect Dis Suppl; 1991; 80():94-104. PubMed ID: 1666450
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.
Andersson J; Sköldenberg B; Ernberg I; Britton S; Henle W; Andersson U
Scand J Infect Dis Suppl; 1985; 47():107-15. PubMed ID: 3006226
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
6. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
7. [The spectrum of infections caused by the Epstein-Barr virus].
Glauser MP
Schweiz Med Wochenschr; 1983 Jul; 113(26):934-8. PubMed ID: 6310735
[TBL] [Abstract][Full Text] [Related]
8. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
[TBL] [Abstract][Full Text] [Related]
9. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
10. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
Davis CL; Harrison KL; McVicar JP; Forg PJ; Bronner MP; Marsh CL
Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
[TBL] [Abstract][Full Text] [Related]
11. [EBV replication and therapy of oral hairy leukoplakia using acyclovir].
Näher H; Helfrich S; Hartmann M; Freese UK
Hautarzt; 1990 Dec; 41(12):680-2. PubMed ID: 1965185
[TBL] [Abstract][Full Text] [Related]
12. [Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin].
Mihara H; Kato Y; Tokura Y; Hattori Y; Sato A; Kobayashi H; Imamura A; Daimaru O; Miwa H; Nitta M
Rinsho Ketsueki; 1999 Dec; 40(12):1258-64. PubMed ID: 10658479
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus associated diseases: an update.
Pathmanathan R
Malays J Pathol; 1993 Dec; 15(2):105-13. PubMed ID: 8065170
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis.
Ernberg I; Andersson J
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2267-72. PubMed ID: 3020162
[TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr-virus-induced lymphoproliferative diseases].
Schuster V; Kreth HW
Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
[TBL] [Abstract][Full Text] [Related]
16. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
17. Update: Epstein-Barr virus-related disease.
Benson CA; Kessler HA
Compr Ther; 1988 Mar; 14(3):58-64. PubMed ID: 2834138
[TBL] [Abstract][Full Text] [Related]
18. A virologic pilot study of valacyclovir in infectious mononucleosis.
Balfour HH; Hokanson KM; Schacherer RM; Fietzer CM; Schmeling DO; Holman CJ; Vezina HE; Brundage RC
J Clin Virol; 2007 May; 39(1):16-21. PubMed ID: 17369082
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
20. [Epstein-Barr virus (EBV)].
Seigneurin JM
Rev Prat; 1999 Dec; 49(20):2217-21. PubMed ID: 10731805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
